Alex H. Gifford

2.9k total citations
60 papers, 1.5k citations indexed

About

Alex H. Gifford is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Hematology. According to data from OpenAlex, Alex H. Gifford has authored 60 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Pulmonary and Respiratory Medicine, 9 papers in Physiology and 7 papers in Hematology. Recurrent topics in Alex H. Gifford's work include Cystic Fibrosis Research Advances (33 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (9 papers) and Tracheal and airway disorders (7 papers). Alex H. Gifford is often cited by papers focused on Cystic Fibrosis Research Advances (33 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (9 papers) and Tracheal and airway disorders (7 papers). Alex H. Gifford collaborates with scholars based in United States, United Kingdom and Japan. Alex H. Gifford's co-authors include Donald A. Mahler, Laurie A. Waterman, George A. O’Toole, Thomas H. Hampton, Christopher H. Goss, Kathryn A. Sabadosa, Mitchell L. Sogin, Bruce C. Marshall, Emily A. Knapp and Todd A. MacKenzie and has published in prestigious journals such as Annals of Internal Medicine, Scientific Reports and Journal of Bacteriology.

In The Last Decade

Alex H. Gifford

58 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alex H. Gifford United States 19 1.1k 339 257 147 94 60 1.5k
Raksha Jain United States 25 1.3k 1.2× 260 0.8× 195 0.8× 250 1.7× 63 0.7× 106 2.0k
Peter Greally Ireland 25 1.0k 0.9× 173 0.5× 242 0.9× 164 1.1× 164 1.7× 66 1.5k
Margaret F. Guill United States 16 821 0.7× 323 1.0× 224 0.9× 155 1.1× 72 0.8× 39 1.3k
Christopher M. Oermann United States 22 1.6k 1.4× 206 0.6× 230 0.9× 460 3.1× 110 1.2× 59 2.0k
Leslie Hazle United States 5 1.3k 1.1× 189 0.6× 171 0.7× 291 2.0× 48 0.5× 6 1.5k
K. Brownlee United Kingdom 23 1.7k 1.5× 269 0.8× 177 0.7× 334 2.3× 195 2.1× 67 2.2k
Erol Gaillard United Kingdom 22 1.1k 1.0× 163 0.5× 761 3.0× 185 1.3× 185 2.0× 104 1.6k
Barry Linnane Ireland 17 1.3k 1.1× 156 0.5× 86 0.3× 206 1.4× 54 0.6× 72 1.5k
Antje Schuster Germany 25 1.1k 0.9× 216 0.6× 1.0k 4.0× 185 1.3× 59 0.6× 74 2.1k
V. Lucidi Italy 26 1.1k 1.0× 342 1.0× 177 0.7× 338 2.3× 87 0.9× 101 2.0k

Countries citing papers authored by Alex H. Gifford

Since Specialization
Citations

This map shows the geographic impact of Alex H. Gifford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alex H. Gifford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alex H. Gifford more than expected).

Fields of papers citing papers by Alex H. Gifford

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alex H. Gifford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alex H. Gifford. The network helps show where Alex H. Gifford may publish in the future.

Co-authorship network of co-authors of Alex H. Gifford

This figure shows the co-authorship network connecting the top 25 collaborators of Alex H. Gifford. A scholar is included among the top collaborators of Alex H. Gifford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alex H. Gifford. Alex H. Gifford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maggs, Jill, G. Sawicki, Lisa Sweeney, et al.. (2024). Qualitative understanding of experiences of people with cystic fibrosis in a treatment discontinuation trial: The QUEST study. Contemporary Clinical Trials. 148. 107752–107752. 1 indexed citations
2.
Jia, Shijing, Jonathan B. Zuckerman, Susan Murray, et al.. (2024). Association between CFTR modulators and changes in iron deficiency markers in cystic fibrosis. Journal of Cystic Fibrosis. 23(5). 878–884. 3 indexed citations
3.
Gifford, Alex H., Margaret Kloster, Richard Russell, et al.. (2023). P090 Treatment use among SIMPLIFY trial participants through 24 weeks of follow-up. Journal of Cystic Fibrosis. 22. S91–S91. 1 indexed citations
4.
5.
Sathe, Meghana, Baha Moshiree, MinJae Lee, et al.. (2022). Need to study simplification of gastrointestinal medication regimen in cystic fibrosis in the era of highly effective modulators. Pediatric Pulmonology. 58(3). 811–818. 2 indexed citations
6.
Crocker, Alex W., et al.. (2021). Calprotectin-Mediated Zinc Chelation Inhibits Pseudomonas aeruginosa Protease Activity in Cystic Fibrosis Sputum. Journal of Bacteriology. 203(13). e0010021–e0010021. 15 indexed citations
7.
Gifford, Alex H., Thida Ong, Christopher F. Dowd, et al.. (2021). Evaluating barriers to and promoters of telehealth during the COVID-19 pandemic at U.S. cystic fibrosis programs. Journal of Cystic Fibrosis. 20. 9–13. 23 indexed citations
8.
Mayer-Hamblett, Nicole, David P. Nichols, Katherine Odem‐Davis, et al.. (2021). Evaluating the Impact of Stopping Chronic Therapies after Modulator Drug Therapy in Cystic Fibrosis: The SIMPLIFY Clinical Trial Study Design. Annals of the American Thoracic Society. 18(8). 1397–1405. 40 indexed citations
9.
Li, Kewei, Alex H. Gifford, Thomas H. Hampton, & George A. O’Toole. (2019). Availability of Zinc Impacts Interactions between Streptococcus sanguinis and Pseudomonas aeruginosa in Coculture. Journal of Bacteriology. 202(2). 11 indexed citations
10.
Gifford, Alex H., et al.. (2019). Answering the call to address cystic fibrosis treatment burden in the era of highly effective CFTR modulator therapy. Journal of Cystic Fibrosis. 19(5). 762–767. 29 indexed citations
11.
May, Teresa, Alex H. Gifford, Thomas Lahiri, et al.. (2017). Complications of long and intermediate term venous catheters in cystic fibrosis patients: A multicenter study. Journal of Cystic Fibrosis. 17(1). 96–104. 16 indexed citations
12.
Mahler, Donald A., Alex H. Gifford, Laurie A. Waterman, et al.. (2014). Antagonism of substance P and perception of breathlessness in patients with chronic obstructive pulmonary disease. Respiratory Physiology & Neurobiology. 196. 1–7. 10 indexed citations
13.
Gifford, Alex H., Zhigang Li, Lisa A. Moulton, et al.. (2013). Iron supplementation does not worsen respiratory health or alter the sputum microbiome in cystic fibrosis. Journal of Cystic Fibrosis. 13(3). 311–318. 25 indexed citations
14.
May, Teresa, et al.. (2013). Complications of Long and Intermediate Term Venous Catheters in CF Patients. CHEST Journal. 144(4). 755A–755A. 1 indexed citations
15.
Mahler, Donald A., Laurie A. Waterman, & Alex H. Gifford. (2012). Prevalence and COPD Phenotype for a Suboptimal Peak Inspiratory Flow Rate against the Simulated Resistance of the Diskus ® Dry Powder Inhaler. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 26(3). 174–179. 92 indexed citations
16.
Mahler, Donald A., et al.. (2011). Mechanism of Greater Oxygen Desaturation During Walking Compared With Cycling in Patients With COPD. CHEST Journal. 140(2). 351–358. 34 indexed citations
17.
Gifford, Alex H., Donald A. Mahler, Laurie A. Waterman, et al.. (2011). Neuromodulatory Effect of Endogenous Opioids on the Intensity and Unpleasantness of Breathlessness during Resistive Load Breathing in COPD. COPD Journal of Chronic Obstructive Pulmonary Disease. 8(3). 160–166. 31 indexed citations
18.
Gifford, Alex H., James C. Leiter, & Harold L. Manning. (2010). Respiratory Function in an Obese Patient With Sleep-Disordered Breathing. CHEST Journal. 138(3). 704–715. 14 indexed citations
19.
Gifford, Alex H., Lisa K. Vande Vusse, & Richard I. Enelow. (2009). LENALIDOMIDE HYPERSENSITIVITY AND LYMPHOCYTIC PLEURAL EFFUSION: A NOVEL ASSOCIATION. CHEST Journal. 136(4). 47S–47S. 1 indexed citations
20.
Gifford, Alex H., Timothy Lahey, & C. Fordham von Reyn. (2006). Fatal hemoptysis from invasiveAspergillus nigerin a patient with cavitary lung disease andMycobacterium avium complexinfection. Medical Mycology. 44(6). 557–560. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Raksha Jain Breakdown of academic impact, for papers by Peter Greally Breakdown of academic impact, for papers by Margaret F. Guill Breakdown of academic impact, for papers by Christopher M. Oermann Breakdown of academic impact, for papers by Leslie Hazle Breakdown of academic impact, for papers by K. Brownlee Breakdown of academic impact, for papers by Erol Gaillard Breakdown of academic impact, for papers by Barry Linnane Breakdown of academic impact, for papers by Antje Schuster Breakdown of academic impact, for papers by V. Lucidi
Rankless by CCL
2026